## Overview
### Goal
Cross-validate novel NMDA-R DCM on human resting-state EEG data using a within- subject design with pharmacological intervention via ketamine.
### Significance
A robust and translational NMDA-R DCM on resting-state data will enable probing the NMDA-R function and studying its effects in many psychiatric and neurological disorders.
## Deliverables
- D1: Evaluation of the NMDA-R DCM’s performance on human pharmacological ketamine data.
- D2: Assessment of the performance of generative embedding.